Viewing StudyNCT02629419

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 7:54 AM
Last Modification Date: 2024-10-26 @ 11:54 AM
Study NCT ID: NCT02629419
Status: COMPLETED
Last Update Posted: 2024-06-07
First Post: 2015-11-16
Brief Title: CAMBMAT2203 in Patients With Mucocutaneous Candidiasis
Sponsor: Matinas BioPharma Nanotechnologies Inc
Organization: Matinas BioPharma Nanotechnologies Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Candidiasis Chronic Mucocutaneous
Keywords:
Name View
Jobs Syndrome Hyperimmunoglobulin E Syndrome Buckley Syndrome View
STAT3 deficient Hyper IgE syndrome View
Gain of function STAT1 defects View
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy APECED View
IL-17IL-22 autoantibodies from thymoma View